Khedr Mohammed A, Salem Tahany A, Boghdadi Ghada M, Elharoun Ahmed S, El-Shahaway Allia A, Atallah Hany R, Sira Mostafa M
Department of Pediatric Hepatology, Gastroenterology and Nutrition, National Liver Institute, Menoufia University, 32511, Shebin El-koom, Menoufia, Egypt.
Department of Immunology Research Laboratories, Microbiology and Immunology, Faculty of Medicine, Zagazig University, 44519, El-Sharkiya, Egypt.
Wien Klin Wochenschr. 2022 Mar;134(5-6):195-201. doi: 10.1007/s00508-021-01907-x. Epub 2021 Jul 20.
Classical autoimmune hepatitis (AIH) is characterized by the presence of conventional autoantibodies (anti-smooth muscle, antinuclear and anti-liver-kidney-microsomal antibodies). The absence of such autoantibodies in some patients does not preclude AIH diagnosis or the need for its treatment. This group of patients was termed seronegative AIH. Whether non-conventional autoantibodies can identify this group of patients is still elusive. We aimed to study the prevalence of seronegativity of conventional autoantibodies and the occurrence of non-conventional autoantibodies in children with AIH.
In this study, 55 children with AIH were investigated for non-conventional autoantibodies (anti-neutrophil cytoplasmic antibodies, antibodies to soluble liver antigen, anti-tissue transglutaminase and antiplatelet antibodies). All the patients received immunosuppressive therapy and were assessed for treatment response.
Of the patients 44 had classical AIH (type 1, 70.09%, type 2, 9.09%) and 20% were seronegative. The four studied non-conventional autoantibodies occurred in four patients, one for each. All non-conventional autoantibodies were exclusively associated with type 1 AIH. The clinical profile, ultrasonographic findings, liver biochemistry and histopathological findings were comparable in the classical and seronegative AIH. The majority of patients with classical (72.7%) and seronegative (54.5%) AIH were treatment responders.
Seronegative AIH represents a substantial percentage of pediatric patients diagnosed with AIH. They were even negative for non-conventional autoantibodies. Furthermore, apart from autoantibodies, seronegative AIH is almost indistinguishable from the classical AIH and the majority of patients were treatment responders. This favorable response to immunosuppression deserves sustainable efforts for considering such a diagnosis and start therapy to halt disease progression is worthwhile.
经典自身免疫性肝炎(AIH)的特征是存在传统自身抗体(抗平滑肌抗体、抗核抗体和抗肝肾微粒体抗体)。部分患者缺乏此类自身抗体并不排除AIH的诊断或治疗需求。这组患者被称为血清阴性AIH。非传统自身抗体能否识别这组患者仍不明确。我们旨在研究AIH患儿中传统自身抗体血清阴性的发生率以及非传统自身抗体的出现情况。
本研究对55例AIH患儿进行了非传统自身抗体(抗中性粒细胞胞浆抗体、可溶性肝抗原抗体、抗组织转谷氨酰胺酶抗体和抗血小板抗体)检测。所有患者均接受免疫抑制治疗,并评估治疗反应。
患者中44例为经典AIH(1型,70.09%;2型,9.09%),20%为血清阴性。所研究的四种非传统自身抗体在4例患者中出现,每种抗体各有1例。所有非传统自身抗体均仅与1型AIH相关。经典AIH和血清阴性AIH在临床特征、超声检查结果、肝脏生化指标和组织病理学检查结果方面具有可比性。经典AIH(72.7%)和血清阴性AIH(54.5%)的大多数患者对治疗有反应。
血清阴性AIH在诊断为AIH的儿科患者中占相当比例。他们甚至对非传统自身抗体也呈阴性。此外,除自身抗体外,血清阴性AIH与经典AIH几乎难以区分,且大多数患者对治疗有反应。这种对免疫抑制的良好反应值得持续关注,考虑到这种诊断并开始治疗以阻止疾病进展是值得的。